Study shows a new approach to treating patients with stage IV Wilms tumour

A new study showing significantly improved survival rates for patients with stage IV Wilms tumours with lung metastases was recently published in the Journal of Clinical Oncology. The outcomes of the study, “Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children’s Oncology Group AREN0533 Study”, will be a game-changer in treating Wilms tumour and reduce the need for radiotherapy – and the long-term risks associated with it – in nearly half of patients whose cancer has spread to the lung.